Fundraising FoxMaxpro Ventures
Venture capitalTaipei · Seed–Late Stage · 7 people tracked
Find your way into Maxpro Ventures
Sign up to see every warm intro you have to Maxpro Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Maxpro Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Maxpro Ventures focuses on biomedical and healthcare innovation, backing companies across areas such as biologic drugs, cell therapy, small molecule drugs, and medical devices. The firm pairs seasoned biomedical scientific expertise with venture capital investment experience to identify and scale transformative healthcare companies in global markets. Beyond capital, it provides strategic guidance to accelerate portfolio companies' development and help bring breakthrough healthcare solutions to patients worldwide, aiming to advance patient outcomes while delivering strong financial returns.
Source: firm website, verified Aug 3, 2026.
Team · 7 people
from the firm's website
What they invest in
from 5 of 33 portfolio companiesBiotech ×5Healthtech ×4Deep Tech ×2Medical Devices ×2AI & Machine Learning ×1Digital Health ×1
HQs:United States×2China×1
Investments · 33 tracked
founders shown can be your intro path
Acepodia develops cell therapies for cancer treatment, leveraging proprietary immune cell engineering and tumor-targeting technology to create off-the-shelf therapeutic options for broad patient populations.
BiotechHealthtechMedical Devices
Patrick Y. Yang(Co-founder, former EVP of Juno Therapeutics, Roche and Genentech)inSonny Hsiao(Co-founder, UC Berkeley cell biologist)
AngenMed develops neoantigen-targeting cell-based cancer immunotherapies, including dendritic cell vaccines and neoantigen-specific T cell products personalized to each patient's tumor mutations.
BiotechDeep TechHealthtech
Apollomics is a biotechnology company focused on discovering and developing oncology therapies designed to combine with other treatments, using approaches that engage the immune system and target specific molecular pathways to inhibit cancer.
BiotechHealthtechFoster City, US
Peter Lin(Executive Officer)Guo-Liang Yu(Founder)Sanjeev Redkar(Founder)
BoardHung-Wen (Howard) Chen(Executive Officer, Director)Hung-Hsien Yen(Director)Yi-Kuei (Alex) Chen(Executive Officer, Director)
Co-investorsPan-Lin CapitalQiming Venture PartnersSVE CapitalK2VC
Arthrosi Therapeutics is a clinical-stage biopharmaceutical company developing treatments for gout, an inflammatory arthritis condition.
BiotechDigital HealthMedical DevicesSan Diego, US
Litain Yeh(Co-Founder & Chief Executive Officer)inShunqi Yan(Co-Founder & Chief Operating Officer)Robert Orr(Executive Officer, Director, Promoter)Yiwei Zong(Director)Jianfeng Fang(Director)
BoardZhang Mingyuan(Director)
Co-investorsHM Venture PartnersHighlight Capital
GenScript Biotech is a life sciences company providing reagents, custom services, instruments, and biologics development solutions to research and pharmaceutical industries globally.
AI & Machine LearningBiotechDeep TechHealthtech
Sherry Shao(Rotating CEO)Phil Zhou(Chief Financial Officer)inRay Chen(President of GenScript Life Science Group)inKening Li(General Counsel and Chief Compliance Officer)inAylin Kosova Bilgin(Chief Marketing & Corporate Communications Officer)inAixi Bai(General Manager of Bestzyme)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ABC-KYACT GenomicsAdvaxisAnbogenAnHornAnyaBraineuLinkEastern Union InteractiveEirgenixElixiron ImmunotherapeuticsForseeFull Chain MaterialsHEC PharmIMEDIPlusImmunworkInPsytechISCOOLLABJHL BiotechLAUNXPLibo PharmaOriginal BiomedicalPolaris PharmaceuticalsProtect Animal HealthStellarCell BioMedicineSyneuRxTAHO PharmaceuticalsTripartite TherapeuticsU-neuron
Portfolio news
latest coverage across their companiesArthrosi · finsmes.com · Oct 8, 2025
Frequently asked questions
- How many investments has Maxpro Ventures made?
- Maxpro Ventures has 33 tracked investments, including 1 dated in the last 24 months.
- What stage does Maxpro Ventures invest at?
- Maxpro Ventures invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Maxpro Ventures focus on?
- Maxpro Ventures focuses on Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices, Retail Tech.
- Where is Maxpro Ventures located?
- Maxpro Ventures is headquartered in Taipei, TW.
- Who does Maxpro Ventures co-invest with?
- Maxpro Ventures most often shares deals with Hive Ventures, HM Venture Partners, Pan-Lin Capital, among 5 tracked co-investors.
Images
Similar investors
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.
Tal Ventures is an Israel-based venture capital group with strong ties to the Israeli high-tech ecosystem, backing startups led by experienced founders whose technologies can make a difference.
New Alliance Capital is a Shanghai-based private equity and venture capital firm founded in 2008, focused on technology-driven sectors. Its backers include state-owned enterprise groups, insurance capital, fund-of-funds, government guidance funds, and listed companies.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Seventure Partners is a European venture capital firm backing innovative companies across life sciences and digital technologies, with additional focus areas in sport & performance and the blue economy.